Physician profile
Andrew J Petrella
NPI 1447397559
$998,885.04
in general payments reported to CMS, 2019-2025
12 companies · $107K in 2025
The $107K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196K · 2020: $157K · 2021: $134K · 2022: $155K · 2023: $134K · 2024: $115K · 2025: $107K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $356K · Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $356,132.11 |
| Food and Beverage | $548.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Development Corporation | $998,357.69 | 2019-2025 | |
| Stryker Corporation | $307.28 | 2020-2025 | Variax, Gamma, T2 Alpha |
| Maxx Orthopedics, INC. | $55.97 | 2023 | |
| Bioventus LLC | $49.37 | 2025 | Xcell, Supartz Fx Sodium Hyaluronate |
| Anika Therapeutics, INC. | $26.32 | 2021-2022 | |
| Cgg Medical INC | $22.44 | 2025 | |
| Heron Therapeutics, INC. | $20.51 | 2025 | Zynrelef |
| Restor3d, INC. | $18.78 | 2025 | |
| Heraeus Medical, LLC. | $13.97 | 2022 | |
| Arthrosurface Incorporated | $12.71 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Petrella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.